These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29857274)

  • 61. Characteristics of infants exposed to maternal tuberculosis and chemoprophylaxis using 3 months of isoniazid and rifampicin.
    Mathivha KT; Velaphi S
    Paediatr Int Child Health; 2017 May; 37(2):129-134. PubMed ID: 27455907
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anti-tubercular treatment regime for Musculoskeletal Tuberculosis.
    Pokharel RK
    JNMA J Nepal Med Assoc; 2006; 45(162):279-80. PubMed ID: 18365358
    [No Abstract]   [Full Text] [Related]  

  • 63. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
    Pandey R; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2005; 85(5-6):415-20. PubMed ID: 16256437
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chitosan/hydroxyapatite (HA)/hydroxypropylmethyl cellulose (HPMC) spongy scaffolds-synthesis and evaluation as potential alveolar bone substitutes.
    Iqbal H; Ali M; Zeeshan R; Mutahir Z; Iqbal F; Nawaz MAH; Shahzadi L; Chaudhry AA; Yar M; Luan S; Khan AF; Rehman IU
    Colloids Surf B Biointerfaces; 2017 Dec; 160():553-563. PubMed ID: 29024920
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Modified n-HA/PA66 scaffolds with chitosan coating for bone tissue engineering: cell stimulation and drug release.
    Zou Q; Li J; Niu L; Zuo Y; Li J; Li Y
    J Biomater Sci Polym Ed; 2017 Sep; 28(13):1271-1285. PubMed ID: 28402219
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid.
    Booysen LL; Kalombo L; Brooks E; Hansen R; Gilliland J; Gruppo V; Lungenhofer P; Semete-Makokotlela B; Swai HS; Kotze AF; Lenaerts A; du Plessis LH
    Int J Pharm; 2013 Feb; 444(1-2):10-7. PubMed ID: 23357255
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Delamanid Kills Dormant Mycobacteria
    Chen X; Hashizume H; Tomishige T; Nakamura I; Matsuba M; Fujiwara M; Kitamoto R; Hanaki E; Ohba Y; Matsumoto M
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373190
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anti-infective efficacy, cytocompatibility and biocompatibility of a 3D-printed osteoconductive composite scaffold functionalized with quaternized chitosan.
    Yang Y; Yang S; Wang Y; Yu Z; Ao H; Zhang H; Qin L; Guillaume O; Eglin D; Richards RG; Tang T
    Acta Biomater; 2016 Dec; 46():112-128. PubMed ID: 27686039
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Trends in tuberculosis treatment duration].
    Veziris N; Aubry A; Truffot-Pernot C
    Presse Med; 2006 Nov; 35(11 Pt 2):1758-1764. PubMed ID: 17086138
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genipin-crosslinked carboxymethyl chitosan nanogel for lung-targeted delivery of isoniazid and rifampin.
    Wu T; Liao W; Wang W; Zhou J; Tan W; Xiang W; Zhang J; Guo L; Chen T; Ma D; Yu W; Cai X
    Carbohydr Polym; 2018 Oct; 197():403-413. PubMed ID: 30007629
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development of poly(vinyl alcohol) porous scaffold with high strength and well ciprofloxacin release efficiency.
    Zhou XH; Wei DX; Ye HM; Zhang X; Meng X; Zhou Q
    Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():326-335. PubMed ID: 27287128
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Poly(vinyl alcohol) hydrogel coatings with tunable surface exposure of hydroxyapatite.
    Moreau D; Villain A; Ku DN; Corté L
    Biomatter; 2014; 4():e28764. PubMed ID: 25482413
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Poly(vinyl alcohol)/collagen/hydroxyapatite hydrogel: properties and in vitro cellular response.
    Song W; Markel DC; Jin X; Shi T; Ren W
    J Biomed Mater Res A; 2012 Nov; 100(11):3071-9. PubMed ID: 22733675
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs.
    Kaur R; Garg T; Malik B; Gupta UD; Gupta P; Rath G; Goyal AK
    Drug Deliv; 2016; 23(3):882-7. PubMed ID: 24870203
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Combinatory activity of linezolid and levofloxacin with antituberculosis drugs in Mycobacterium tuberculosis.
    Santos NCS; Scodro RBL; de Almeida AL; Baldin VP; Nakamura de Vasconcelos SS; Siqueira VLD; Caleffi-Ferracioli KR; Campanerut-Sá PAZ; Cardoso RF
    Tuberculosis (Edinb); 2018 Jul; 111():41-44. PubMed ID: 30029913
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.
    Nuermberger E; Rosenthal I; Tyagi S; Williams KN; Almeida D; Peloquin CA; Bishai WR; Grosset JH
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2621-5. PubMed ID: 16870750
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preparation and in vitro characterization of electrospun PVA scaffolds coated with bioactive glass for bone regeneration.
    Gao C; Gao Q; Li Y; Rahaman MN; Teramoto A; Abe K
    J Biomed Mater Res A; 2012 May; 100(5):1324-34. PubMed ID: 22374712
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
    Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MDR-TB Antibody Response (Western Blot) to Fractions of Isoniazid and Rifampicin Resistant Antigens of Mycobacterium tuberculosis.
    Hadizadeh Tasbiti A; Yari S; Ghanei M; Shokrgozar MA; Bahrmand A
    Curr Microbiol; 2015 Dec; 71(6):638-42. PubMed ID: 26316231
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis.
    Sharma R; Saxena D; Dwivedi AK; Misra A
    Pharm Res; 2001 Oct; 18(10):1405-10. PubMed ID: 11697465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.